Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Francisco Jose Gimenez

A Real-Time Feedback System For Radiological Reporting To Reduce Diagnostic Variation

Breast

Radiation Oncology

Ellen P Mccarthy

Integrating Competing Risks into the CISNET DFCI Breast Cancer Model

Breast

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Hodgkin lymphoma Non-Hodgkin lymphoma

Jun Chung

ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer

Breast

Eduardo M. Sotomayor

Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy

Hodgkin lymphoma Non-Hodgkin lymphoma

Robert Michael Angelo

Predictive signatures in breast cancer using multiplexed ion beam imaging

Breast

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia